Exact Sciences (EXAS) Profit Margin (2010 - 2025)
Exact Sciences (EXAS) profit margin from Jun 30, 2010 to Dec 31, 2025. The current Exact Sciences (EXAS) profit margin is -9.79%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Exact Sciences (EXAS)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -6.40% | -82.83% |
| 2024 | -37.29% | N/A |
| 2024 | 0.00% | N/A |
| 2024 | 0.00% | N/A |
| 2024 | 0.00% | -100.00% |
| 2023 | -8.17% | -6595.57% |
| 2023 | 0.13% | -100.97% |
| 2023 | -13.03% | +5.83% |
| 2023 | -12.31% | -58.86% |
| 2022 | -29.91% | -11.25% |
| 2021 | -33.71% | N/A |
| 2021 | 0.00% | N/A |
| 2021 | 0.00% | N/A |
| 2021 | 0.00% | -100.00% |
| 2020 | -55.22% | +11.34% |
| 2020 | -49.60% | +95.85% |
| 2020 | -25.32% | -34.58% |
| 2020 | -38.71% | +59.19% |
| 2019 | -24.32% | +31.31% |
| 2019 | -18.52% | -3.86% |
| 2019 | -19.26% | -62.37% |
| 2019 | -51.18% | +32.81% |
| 2018 | -38.54% | +0.51% |
| 2018 | -38.35% | +8.42% |
| 2018 | -35.37% | -18.98% |
| 2018 | -43.65% | +1.50% |
| 2017 | -43.01% | +16.03% |
| 2017 | -37.07% | -30.60% |
| 2017 | -53.41% | -26.10% |
| 2017 | -72.27% | -57.05% |
| 2016 | -168.25% | -57.95% |
| 2015 | -400.10% | -92.80% |
| 2014 | -5558.33% | +394.76% |
| 2013 | -1123.43% | +4.69% |
| 2013 | -1073.08% | -9.34% |
| 2013 | -1183.65% | +13.46% |
| 2013 | -1043.27% | -17.61% |
| 2012 | -1266.18% | +1.69% |
| 2012 | -1245.19% | -12.74% |
| 2012 | -1426.92% | +39.47% |
| 2012 | -1023.08% | +48.45% |
| 2011 | -689.18% | -7.75% |
| 2011 | -747.12% | +17.37% |
| 2011 | -636.54% | +51.49% |
| 2011 | -420.19% | +94.10% |
| 2010 | -216.48% | +12.86% |
| 2009 | -191.81% | N/A |
Comparison Exact Sciences (EXAS) profit margin with competitors
Exact Sciences (EXAS) profit margin is -9.79%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 24.41% | -349.46% |
| VCYT | Veracyte Inc | 20.64% | -310.93% |
| QGEN | Qiagen NV | 20.33% | -307.77% |
| MTD | Mettler-Toledo International Inc | 17.89% | -282.83% |
| MEDP | Medpace Holdings Inc | 17.53% | -279.15% |
| DHR | Danaher Corp | 17.29% | -276.70% |
| A | Agilent Technologies Inc | 16.96% | -273.33% |
| BLLN | Billiontoone Inc - Class A | 16.58% | -269.44% |
| TMO | Thermo Fisher Scientific Inc | 15.00% | -253.29% |
| ILMN | Illumina Inc | 12.28% | -225.50% |
| SHC | Sotera Health Company | 9.49% | -196.98% |
| DGX | Quest Diagnostics Inc | 8.70% | -188.91% |
| LH | Laboratory Corp Of America Holdings | 7.85% | -180.22% |
| IQV | IQVIA Holdings Inc | 6.60% | -167.45% |
| FONR | Fonar Corp | 6.20% | -163.36% |
| RVTY | Revvity Inc | 5.73% | -158.56% |
| ICLR | Icon Plc | 2.78% | -128.41% |
| CDNA | Caredx Inc | 2.39% | -124.42% |